Microparticles in COVID-19 as a link between lung injury extension and thrombosis
Open Access
- 1 April 2021
- journal article
- letter
- Published by European Respiratory Society (ERS) in ERJ Open Research
Abstract
Procoagulant microparticles are associated with the extent of lung injuries in #COVID19 and pulmonary thrombosishttps://bit.ly/3eX2LPcKeywords
Funding Information
- Boehringer Ingelheim
This publication has 14 references indexed in Scilit:
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19The New England Journal of Medicine, 2020
- Exosome-Mediated Transfer of ACE2 (Angiotensin-Converting Enzyme 2) from Endothelial Progenitor Cells Promotes Survival and Function of Endothelial CellOxidative Medicine and Cellular Longevity, 2020
- Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and ThrombogenicityCirculation, 2017
- Cell-derived microparticles and the lungEuropean Respiratory Review, 2016
- Microparticles, Vascular Function, and AtherothrombosisCirculation Research, 2011
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticlesJournal of Thrombosis and Haemostasis, 2003
- Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilolJournal of the American College of Cardiology, 2000
- Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary SyndromesCirculation, 2000
- The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.JCI Insight, 1997